Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States

IMPORTANCE: The antifungal medication voriconazole is used to prevent and treat aspergillosis, a major cause of mortality among recipients of lung transplants (hereinafter referred to as lung recipients). Small studies suggest that voriconazole increases risk of cutaneous squamous cell carcinoma (SC...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Arcy, Monica E., Pfeiffer, Ruth M., Rivera, Donna R., Hess, Gregory P., Cahoon, Elizabeth K., Arron, Sarah T., Brownell, Isaac, Cowen, Edward W., Israni, Ajay K., Triplette, Matthew A., Yanik, Elizabeth L., Engels, Eric A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221851/
https://www.ncbi.nlm.nih.gov/pubmed/32401271
http://dx.doi.org/10.1001/jamadermatol.2020.1141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221851/
https://www.ncbi.nlm.nih.gov/pubmed/32401271
http://dx.doi.org/10.1001/jamadermatol.2020.1141

Ejemplares similares